Screener
Cyclerion Therapeutics CYCN Q1 2026 Annual earnings
Reported May 12, 2026 · After market close
EPS-$0.76Beat by $16.44
EPS estimate-$17.20
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$900.0K
EPS estimate-$6.00
Versus estimates
Diluted EPS
Q2 2026-$0.41Beat by $6.69
Q1 2026-$0.76Beat by $16.44
Q4 2025-$0.19Beat by $0.19Q1 2024-$0.38In lineQ3 2025-$0.30Q2 2025-$0.11FAQ
- When did Cyclerion Therapeutics report Q1 2026 earnings?
- Cyclerion Therapeutics (CYCN) reported Q1 2026 earnings on May 12, 2026 after market close.
- What were Cyclerion Therapeutics's Q1 2026 revenue and EPS?
- Cyclerion Therapeutics reported eps of $-0.76 for Q1 2026.
- Did Cyclerion Therapeutics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-17.20 by $16.44.
- How did Cyclerion Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 35.7% from $-0.56.
- Where can I find Cyclerion Therapeutics's Q1 2026 SEC filings?
- You can read the 10-K/A periodic report (0001193125-26-194204) directly on SEC EDGAR. The filing index links above go to sec.gov.
